Hybrid mass spectrometry methods reveal lot-to-lot differences and delineate the effects of glycosylation on the tertiary structure of Herceptin®. (2019)
Attributed to:
CENTRE FOR SYNTHETIC BIOLOGY OF FINE AND SPECIALITY CHEMICALS
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/c8sc05029e
PubMed Identifier: 30997002
Publication URI: http://europepmc.org/abstract/MED/30997002
Type: Journal Article/Review
Volume: 10
Parent Publication: Chemical science
Issue: 9
ISSN: 2041-6520